Status:
COMPLETED
Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008
Lead Sponsor:
Pfizer
Conditions:
Chronic Myeloid Leukemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of the study is to provide long term access to bosutinib treatment and assess long term safety, tolerability and duration of clinical benefit, without any formal hypothesis testing; ther...
Eligibility Criteria
Inclusion
- Only subjects previously participating in two specific studies are eligible to enroll into this study. Enrollment is not open to subjects if not previously enrolled in studies B1871006 or B1871008.
Exclusion
- All subjects are excluded unless previously participating in studies B1871006 or B1871008.
Key Trial Info
Start Date :
August 28 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 5 2020
Estimated Enrollment :
281 Patients enrolled
Trial Details
Trial ID
NCT01903733
Start Date
August 28 2013
End Date
June 5 2020
Last Update
July 19 2022
Active Locations (91)
Enter a location and click search to find clinical trials sorted by distance.
1
Orlando Health, Inc
Orlando, Florida, United States, 32806
2
Emory University Hospital
Atlanta, Georgia, United States, 30322
3
The Emory Clinic
Atlanta, Georgia, United States, 30322
4
Winship Cancer Institute, Emory University
Atlanta, Georgia, United States, 30322